epidermal pentapeptide has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
| Studies (epidermal pentapeptide) | Trials (epidermal pentapeptide) | Recent Studies (post-2010) (epidermal pentapeptide) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
|---|---|---|---|---|---|
| 20 | 0 | 1 | 6,010 | 10 | 772 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elgjo, K; Iversen, OH; Paulsen, JE; Reichelt, KL | 1 |
1 other study(ies) available for epidermal pentapeptide and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Moderate enhancement of the promotion phase of skin tumorigenesis in hairless mice by topical pretreatment with a mitosis-inhibiting epidermal pentapeptide.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Amino Acid Sequence; Animals; Carcinogens; Mice; Mice, Hairless; Mitosis; Molecular Sequence Data; Oligopeptides; Papilloma; Pyrrolidonecarboxylic Acid; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1993 |